New dispensary expands patient access to medical cannabis; grand opening specials available
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical cannabis dispensary in Riverview, Florida. Located at 9912 Upper Alafia Court, the doors will open at 9 a.m. on Thursday, February 10, 2022. This is Trulieve's 112th dispensary in Florida and its 161st nationwide.
There will be deals and specials throughout opening day, including a 25% discount for all registered patients at the new dispensary in Riverview. Grand opening festivities will include music, numerous partner giveaways and complimentary food from local vendors, Chill Cawfee and the veteran-owned Happy Ending Food Truck.
As always, all first-time guests are eligible for a 50% new customer discount at any Florida-based location. Trulieve also offers statewide home delivery, convenient online ordering and in-store pickup.
As the state's leading medical cannabis provider, Trulieve's retail employees are trained to provide personalized patient care and support individuals at every stage of their cannabis journey. Trulieve dispensaries throughout Florida offer on-site consultations to help patients obtain appropriate medical products and dosages to ensure optimal cannabis experiences.
"Trulieve is excited to expand access to medical cannabis in Riverview and build strong relationships in the community," said Kim Rivers, CEO of Trulieve. "Our company is driven by our commitment to providing tailored, high-quality patient care to as many patients as possible."
Trulieve patients across Florida can choose from the largest selection of THC and CBD products available in a variety of consumption methods, including smokable flower, concentrates, edibles, capsules, syringes, tinctures, topical creams, vaporizers, and more. Patients have access to nationally-beloved brands such as Bellamy Brothers, Bhang, Binske, Blue River, Black Tuna, Love's Oven, O.pen, and Sunshine Cannabis, all available exclusively at Trulieve in Florida.
For more information, or to learn how to become a registered patient, please visit Trulieve.com and connect on Instagram or Facebook.
About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.
Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve
Investor Contact
Christine Hersey, Director of Investor Relations
+1 (424) 202-0210
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Contact
Rob Kremer, Executive Director of Corporate Communications
+1 (404) 218-3077
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$4.83 |
Daily Change: | 0.05 1.05 |
Daily Volume: | 102,130 |
Market Cap: | US$801.590M |
December 13, 2024 December 09, 2024 November 19, 2024 |
GreenPower Motor designs, builds and distributes a full suite of high-floor and low-floor all-electric medium and heavy-duty vehicles, including transit buses, school buses, shuttles, cargo van, and a cab and chassis...
CLICK TO LEARN MORELeveraging its vertically-integrated approach from mine to material manufacturing, Graphite One intends to produce high-grade anode material for the lithium-ion electric vehicle battery market and energy storage systems...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS